United States · Series A startup

Who invested in NuMedii

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$5.5Mraised across 2 rounds since 2013, from 2 sources

$3.5MSeries A$2.0MSeries A
Latest round
Series A, $2.0MAug 2015
Biggest round
$3.5MSeries A · Jun 2013
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20142015
$3.5MSeries A$2.0MSeries A
First round
Series A, $3.5M
Jun 2013
Biggest round
$3.5M
Series A · Jun 2013
Between rounds
2.2 years
from the last two

The rounds

  1. Aug 2015
  2. Jun 2013

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

TEEC Angel FundVC firm1round
Seraph GroupAngel network1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about NuMedii

Who invested in NuMedii?

NuMedii's investors include Lightspeed Venture Partners, Claremont Creek Ventures, TEEC Angel Fund, Seraph Group and The Stanford StartX Fund.

How much has NuMedii raised?

NuMedii has raised $5.5M across 2 rounds since 2013.

When did NuMedii last raise?

NuMedii's most recent round was a Series A of $2.0M in Aug 2015.

What was NuMedii's biggest round?

NuMedii's largest round on record is $3.5M (Series A), in Jun 2013.

Who backed NuMedii first?

NuMedii's first round on record, in Jun 2013, was backed by Lightspeed Venture Partners and Claremont Creek Ventures.

What stage is NuMedii at?

NuMedii's latest named round is a Series A, in Aug 2015.

Where is NuMedii based?

NuMedii is based in the United States.

Companies like NuMedii

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.